|
World Health Organization WHO
(2022)
CC
|
|
|
World Health Organization WHO
(2022)
C_WHO
|
|
|
World Health Organization WHO
(2022)
CC
CONVIDECIA is based on a modified human adenovirus that expresses the spike S protein of SARS-CoV-2. It is administered as a single dose.
|
|
|
World Health Organization WHO
(2022)
C_WHO
|
|
|
Kamradt, T., and B.S. Kamps
(2021)
CC
COVID Reference 23 May 2021
Tags: 
vaccine candidates,
COVID-19,
SARS-CoV-2,
mRNA,
Moderna,
pfizer,
Astra Zeneca,
development,
vaccine trial,
Scientific Updates,
|
|
|
Kamradt, T., B.S. Kamps J. García-Rosales Delgado
(2021)
CC
COVID Reference 23 May 2021
Tags: 
vaccine candidates,
COVID-19,
SARS-CoV-2,
mRNA,
Moderna,
pfizer,
Astra Zeneca,
development,
vaccine trial,
Scientific Updates,
|
|
|
Tags: 
Vaccination,
Access,
strategy,
Immunization,
Guidelines,
global initiatives,
vaccine candidates,
research,
vaccine trial,
resources,
|
|
|
Robert-Koch-Institut RKI
(2021)
CC
|
|
|
Robert-Koch-Institut RKI
(2021)
C1
INFO Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019)–mit Vektor-Impfstoff –
|
|
|
New England Journal of Medicine
(2021)
C1
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
|
|